SUMO 2/3, Human Antibody from NKMAX Co. Ltd.
Search, find, compare suppliers for anti-SUMO 2/3, Human antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | SUMO 2/3, Human |
| Clone | AT10F1 |
| Host Species | Mouse |
| Reactive Species | human |
| Isotype | IgG2b kappa |
| Format | Protein G purified |
| Size | 50ul, 100ul |
| Concentration | 1mg/ml (determined by BCA assay) |
| Applications | ELISA, WB, ICC/IF, IHC, FACS |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | SUMO (small ubiquitin-related modifier) is the best-characterized member of a growing family of ubiquitin-related proteins. 8-11 kDa that covalently modify various intracellular proteins. It resembles ubiquitin in its structure, its ability to be ligated to other proteins. SUMO regulates cellular function of a variety of target proteins. SUMO proteins are expressed as their precursor forms. Cleavage of the residues after the GG region of these precursors by SUMO-specific proteases in maturation is a prerequisite for subsequent sumoylation. Notably, SUMO2 and SUMO3 precursors have 96% sequence identity, and recent studies have shown protein substrates conjugated with SUMO2 or SUMO3 have similar, if not identical, biological consequences. |
| Immunogen | Recombinant human SUMO2 (1-93aa) purified from E.coli |
| Other Names | ubiquitin like protein SMT3B.Small ubiquitin-related modifier 3, SuMO3, SuMO2, SMT3H2, SMT3H1, SMT3B, SMT3A, SMT3 suppressor of mif two 3 homolog 2, SMT3 homolog 2, SMT 3B, Small ubiquitin-related modifier 2 SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae), Small ubiquitin related modifier 2, Small ubiquitin like modifier 2, Sentrin2, MGC117191, HSMT3 |
| Gene, Accession # | NCBI: NP_008868, UniProt: P61956 |
| Catalog # | ATGA0184 |
| Price | $170, $290 |
| Order / More Info | SUMO 2/3, Human Antibody from NKMAX Co. Ltd. |
| Product Specific References | Ham JH, et al. An Immunohistochemical Study on the Expression of SUMO-2/3 in the Colorectal Carcinoma. (Soonchunhyang Med Sci. 2012){https://jsms.sch.ac.kr/journal/view.php?year=2012&vol=18&no=2&spage=95} |
NKMAX Co. Ltd.
NKMAX Co. Ltd.
6F, SNUH Health Care Innovation Park
172 Dolma-ro, Bundang-gu
Seongnam-si, Gyeonggi-do 13605 REPUBLIC OF KOREA
P: +82-31-8017-8114
F: +82-31-8017-8124
salesbio@nkmax.com
http://www.nkmaxbio.com
Profile of NKMAX Co. Ltd.